Identification of hematein as a novel inhibitor of protein kinase CK2 from a natural product library
2009 · BMC Cancer · 30 citations
https://doi.org/10.1186/1471-2407-9-135
M
Ming‐Szu Hung
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
77
Papers
1.4K
Citations
21
h-index
34
i10-index
Ming‐Szu Hung is an academic researcher from Chang Gung University of Science and Technology. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Sepsis Diagnosis and Treatment & Lung Cancer Diagnosis and Treatment. The author has an h-index of 21, co-authored 66 publications.
ORCID: 0000-0002-5742-7932Papers by this author
worksA highly sensitive and specific real-time quantitative PCR for BRAF V600E/K mutation screening
2020 · Scientific Reports · 10 citations
https://doi.org/10.1038/s41598-020-72809-7
Serum vascular endothelial growth factor affects tissue fluid accumulation and is associated with deteriorating tissue perfusion and oxygenation in severe sepsis: a prospective observational study
2023 · European journal of medical research · 9 citations
https://doi.org/10.1186/s40001-023-01119-1
The association of aspirin use with overall survival of patients with inoperable non-small cell lung cancer: a retrospective study
2021 · BMC Cancer · 7 citations
https://doi.org/10.1186/s12885-021-08999-8
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat